Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
基本信息
- 批准号:10459602
- 负责人:
- 金额:$ 81.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdultAdverse effectsAdverse eventAdvertisementsAmbulatory CareAmericanAnxietyBehavior TherapyBuprenorphineCOVID-19COVID-19 impactCOVID-19 pandemicCapitalCellular PhoneCollaborationsCommunitiesComplementControl GroupsCountyDataData SetDistressDrug usageEducationElectronic Health RecordEmergency department visitEnrollmentEthicsEthnic OriginEvidence based treatmentFacebookGeographyGovernmentGrantHealthHealth Services AccessibilityHomeIncidenceIncomeIndianaIndividualInterventionIntervention StudiesLonelinessLow incomeMeasuresMethodsMinority GroupsNatural Language ProcessingOutcomeParticipantPatient Outcomes AssessmentsPatient Self-ReportPatientsPersonsPharmaceutical PreparationsProcessPsychosocial StressPublic HealthQuality of lifeRaceRandomizedRandomized Controlled TrialsRecording of previous eventsRecoveryRecovery SupportRecurrenceRegulationReportingResearchResourcesRhode IslandRuralSamplingSecureSecuritySelf EfficacySelf-Injurious BehaviorServicesSocial supportSocioeconomic StatusStressStructureSupport GroupsSystemTestingTextTimeTreatment/Psychosocial EffectsUnited StatesValidationVulnerable Populationsacceptability and feasibilityaddictionadministrative databasebarrier to carebaseclinically relevantdensitydepressive symptomsdigital healthefficacy studyefficacy testingethnic minority populationevidence baseexperiencefollow-upimprovedintervention effectlow socioeconomic statusmobile applicationnovelopioid overdoseopioid use disorderoverdose riskpandemic diseasepeerpeer supportpreventprimary endpointprimary outcomeprogramspsychosocialracial minorityrecruitresponserural areasecondary endpointsecondary outcomesocialsocial groupsocial mediasocial stigmasubstance usetooltreatment as usualtreatment program
项目摘要
PROJECT SUMMARY
Increasing numbers of opioid overdoses have been observed during the COVID-19 pandemic, likely reflecting
the pandemic’s multiple effects on this already vulnerable population. People in recovery from opioid use disorder
(OUD) have reported disproportionate psychosocial distress and isolation, as well as significant disruptions in
access to treatment including peer support, during the COVID-19 pandemic. These negative outcomes are
especially acute for rural, low-income, and minority populations in recovery from OUD. Peer support is a key
component of many evidence-based OUD recovery programs: it improves recovery capital, improves treatment
engagement, improves perceived social support, and reduces psychosocial distress, particularly when used in
conjunction with other evidence-based treatments such as medication for opioid use disorder (MOUD). This
grant, submitted in response to PA 20-237, therefore proposes a randomized controlled trial of a novel mobile
peer support app platform among a national sample of 1300 patients in recovery from opioid use disorders
(OUDs), as an adjunct to usual care, during COVID-19. Our previously piloted online-only recruitment and follow-
up strategy – in which we meld patient-reported outcomes with administrative datasets – allows strategic
recruitment of often-excluded participants from across the United States, including those facing the highest
barriers to treatment. The mobile app-based peer support intervention, provided as an individual-level
enhancement of existing treatment and recovery programs, will allow individuals in OUD recovery to access a
tailored, anonymous, peer-moderated support group 24/7. The app is augmented with natural language
processing tools capable of automatically ‘flagging’ critical or clinically relevant content, thereby creating a
scalable system to keep groups safe and constructive. Participants will be followed for 6 months through both
self-report and administrative outcomes. The study’s primary outcome is self-reported recovery capital,
complemented by objectively measured administrative data on retention in treatment programs from our
community and governmental partners in a sub-sample of 650 patients from RI and IN. Hypothesized secondary
outcomes are mitigation of psychosocial effects of COVID-19 on this vulnerable population, including depressive
symptoms, stress, and loneliness, as well as objective adverse events of emergency department visits and opioid
overdoses. Finally, we will explore whether state- and county-level variables moderate efficacy. SIGNIFICANCE:
OUD is a major public health problem, and patients in recovery from OUD are experiencing worse outcomes
during the COVID-19 pandemic. If this mobile app demonstrates efficacy among a large national sample of
patients, it has the potential to augment existing treatment programs, improve recovery capital, and reduce
disproportionate impacts of COVID-19 on this vulnerable population.
项目总结
在新冠肺炎大流行期间观察到越来越多的阿片类药物过量,这可能反映了
这场大流行对本已脆弱的人群产生了多重影响。人们正在从阿片类药物使用障碍中恢复
(OUD)报告了不成比例的心理社会痛苦和孤立,以及在
在新冠肺炎大流行期间获得包括同行支持在内的治疗。这些负面结果是
尤其是对农村、低收入和少数民族人口来说,他们正在从乌尔德人的生活中恢复。同伴的支持是关键
许多循证康复计划的组成部分:它提高了康复资本,改善了治疗
参与度,改善感受到的社会支持,并减少心理社会痛苦,特别是在
与其他循证治疗相结合,如阿片类药物使用障碍(Moud)。这
因此,Grant应PA 20-237提交,建议对一种新型移动设备进行随机对照试验
全国1300名阿片类药物使用障碍康复期患者同伴支持APP平台调查
(ODS),作为常规护理的补充,在新冠肺炎期间。我们之前试点的仅限在线招聘和跟踪-
UP策略-我们将患者报告的结果与管理数据集相结合-允许战略
从全美各地招募经常被排除在外的参与者,包括那些面临最高
治疗的障碍。基于移动应用的同伴支持干预,作为个人级别提供
加强现有的治疗和康复计划,将使处于康复中的个人能够获得
定制的、匿名的、由同行主持的全天候支持小组。该应用程序使用自然语言进行了增强
能够自动标记关键或临床相关内容的处理工具,从而创建
可扩展的系统,以确保团队的安全和建设性。参与者将接受为期6个月的跟踪调查
自我报告和行政结果。这项研究的主要结果是自我报告的复苏资本,
辅以来自我们的治疗计划中关于保留的客观测量的管理数据
来自RI和IN的650名患者的子样本中的社区和政府合作伙伴。假想的二级
结果是新冠肺炎对这一弱势群体的心理社会影响得到缓解,包括抑郁
急诊科就诊和阿片类药物的症状、压力、孤独以及客观不良事件
吸毒过量。最后,我们将探讨州和县级变量是否具有适度的疗效。重要意义:
OUD是一个主要的公共卫生问题,从OUD恢复中的患者正在经历更糟糕的结果
在新冠肺炎大流行期间。如果这款移动应用程序在全国范围内的大样本中显示出有效性
患者,它有可能增加现有的治疗计划,提高恢复资本,并减少
新冠肺炎对这一弱势群体的影响不成比例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francesca Beaudoin其他文献
Francesca Beaudoin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Francesca Beaudoin', 18)}}的其他基金
Injury Control Research to Practice and Policy Core
伤害控制研究实践和政策核心
- 批准号:
10331945 - 财政年份:2022
- 资助金额:
$ 81.06万 - 项目类别:
Identifying optimal buprenorphine dosing for OUD treatment and prevention of overdose
确定 OUD 治疗的最佳丁丙诺啡剂量和预防过量
- 批准号:
10524852 - 财政年份:2022
- 资助金额:
$ 81.06万 - 项目类别:
Injury Control Research to Practice and Policy Core
伤害控制研究实践和政策核心
- 批准号:
10598065 - 财政年份:2022
- 资助金额:
$ 81.06万 - 项目类别:
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
- 批准号:
10672255 - 财政年份:2021
- 资助金额:
$ 81.06万 - 项目类别:
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
- 批准号:
10308885 - 财政年份:2021
- 资助金额:
$ 81.06万 - 项目类别:
Opioid use in post-acute hip fracture care: prescribing patterns, effectiveness, and safety
阿片类药物在急性髋部骨折后护理中的使用:处方模式、有效性和安全性
- 批准号:
9980239 - 财政年份:2019
- 资助金额:
$ 81.06万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 81.06万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 81.06万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 81.06万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 81.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 81.06万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 81.06万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 81.06万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 81.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 81.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 81.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




